Last Updated: November 16, 2026

Investigational Drug Information for Balovaptan

« Back to Dashboard


What is the drug development status for Balovaptan?

Balovaptan is an investigational drug.

There have been 12 clinical trials for Balovaptan. The most recent clinical trial was a Phase 1 trial, which was initiated on August 8th 2018.

The most common disease conditions in clinical trials are Autism Spectrum Disorder, Disease, and Child Development Disorders, Pervasive. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].

There are twenty US patents protecting this investigational drug.

Recent Clinical Trials for Balovaptan
TitleSponsorPhase
The Effect of Hepatic Impairment on the Pharmacokinetics of BalovaptanHoffmann-La RochePhase 1
Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at High Risk of Developing Malignant Brain EdemaHoffmann-La RochePhase 2
Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)Hoffmann-La RochePhase 2

See all Balovaptan clinical trials

Clinical Trial Summary for Balovaptan

Top disease conditions for Balovaptan
Top clinical trial sponsors for Balovaptan

See all Balovaptan clinical trials

US Patents for Balovaptan

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Balovaptan ⤷  Start Trial Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof Hoffmann La Roche Inc ⤷  Start Trial
Balovaptan ⤷  Start Trial V1A antagonists to treat phase shift sleep disorders Hoffmann La Roche Inc ⤷  Start Trial
Balovaptan ⤷  Start Trial Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof Hoffmann La Roche Inc ⤷  Start Trial
Balovaptan ⤷  Start Trial Triazolobenzazepines as vasopressin V1a receptor antagonists Richter Gedeon Nyrt ⤷  Start Trial
Balovaptan ⤷  Start Trial Compositions and methods for treating anxiety-related disorders Yamo Pharmaceuticals LLC ⤷  Start Trial
Balovaptan ⤷  Start Trial Regulated biocircuit systems Obsidian Therapeutics Inc ⤷  Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.